Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
Fox Chase Cancer Center
Fox Chase Cancer Center
Eli Lilly and Company
Generate Biomedicines
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GI Innovation, Inc.
University of California, San Francisco
Merck Sharp & Dohme LLC
Astellas Pharma Inc
Mayo Clinic
Neonc Technologies, Inc.
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
Merck Sharp & Dohme LLC
Genentech, Inc.
Merck Sharp & Dohme LLC
University of Oklahoma
University of California, Davis
Massachusetts General Hospital
ImmunityBio, Inc.
Seagen Inc.